ISEQ up as Elan drug gets the nod

The ISEQ index of shares continued its upward trend this morning, gaining 36.17 to 7387.98.

ISEQ up as Elan drug gets the nod

The ISEQ index of shares continued its upward trend this morning, gaining 36.17 to 7387.98.

The hike came as Elan Corporation plc and Biogen Idec announced that they received approval from the European Commission to market Tysabri as a treatment for multiple sclerosis (MS). Elan shares were up 12c to €13.37 this morning.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited